نتایج جستجو برای: quality adjusted life year qaly algorithm

تعداد نتایج: 2563587  

Journal: :Medical care 2011
Fei-Li Zhao Ming Yue Hua Yang Tian Wang Jiu-Hong Wu Shu-Chuen Li

OBJECTIVE To estimate the willingness to pay (WTP) per quality-adjusted life year (QALY) ratio with the stated preference data and compare the results obtained between chronic prostatitis (CP) patients and general population (GP). METHODS WTP per QALY was calculated with the subjects' own health-related utility and the WTP value. Two widely used preference-based health-related quality of life...

2015
Kenichi Meguro Kyoko Akanuma Mitsue Meguro Mari Kasai Hiroshi Ishii Satoshi Yamaguchi

BACKGROUND We previously demonstrated a positive correlation with nursing home (NH) replacement and donepezil (DNP) administration on lifetime expectancy after the onset of Alzheimer's disease (AD). However, the correlation with quality-adjusted life-year (QALY) remains to be elucidated, along with the additional impact of concomitant cerebrovascular disease (CVD). Based upon our recently repor...

Journal: :Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology 2015
João Ferreira Ana Mirco

INTRODUCTION AND OBJECTIVES Novel oral anticoagulants are emerging options for the prevention and treatment of thromboembolic diseases. They are increasingly used in clinical practice due to their simplicity of use and clinical benefits, but an important step is to evaluate their cost-effectiveness. The aim of the AFFORD study (A Review of Cost EFFectiveness of Novel ORal Anticoagulant Drugs) w...

Journal: :Journal of physical activity & health 2008
Larissa Roux Mike Pratt I-Min Lee Terry Bazzarre David Buchner

BACKGROUND Community-based efforts to promote physical activity (PA) in adults have been found to be cost-effective in general, but it is unknown if this is true in middle-age specifically. Age group-specific economic evaluations could help inform the design and delivery of better and more tailored PA promotion. METHODS A Markov model was developed to estimate the cost-effectiveness (CE) of 7...

2010
José L. Burgos Julia A. Gaebler Steffanie A. Strathdee Remedios Lozada Hugo Staines Thomas L. Patterson

BACKGROUND Previous research demonstrated efficacy of a brief behavioral intervention to reduce incidence of HIV and sexually transmitted infections (STIs) among female sex workers (FSWs) in Tijuana and Ciudad Juarez, Mexico, cities on Mexico's border with the US. We assessed this intervention's cost-effectiveness. METHODOLOGY AND PRINCIPAL FINDINGS A life-time Markov model was developed to e...

Journal: :Archives of otolaryngology--head & neck surgery 2003
Manuela A Joore Hans Van Der Stel Hans J M Peters Gijs M Boas Lucien J C Anteunis

OBJECTIVE To determine the cost-effectiveness of hearing-aid fitting. DESIGN Cost-effectiveness analysis using a Markov model based on aggregate data and results from a prospective intervention study. SETTING The cost-effectiveness study was based in the general community. The prospective study was hospital based, as 85% of the first-time hearing-aid users attend a hospital in the process o...

Journal: :Journal of the American College of Cardiology 2015
Vivek Y Reddy Ronald L Akehurst Shannon O Armstrong Stacey L Amorosi Stephen M Beard David R Holmes

BACKGROUND Left atrial appendage closure (LAAC) and nonwarfarin oral anticoagulants (NOACs) have emerged as safe and effective alternatives to warfarin for stroke prophylaxis in patients with nonvalvular atrial fibrillation (AF). OBJECTIVES This analysis assessed the cost-effectiveness of warfarin, NOACs, and LAAC with the Watchman device (Boston Scientific, Marlborough, Massachusetts) for st...

Journal: :Cost Effectiveness and Resource Allocation : C/E 2009
Werner A Scherbaum Gordon Goodall Katrina M Erny-Albrecht Massimo Massi-Benedetti Erland Erdmann William J Valentine

BACKGROUND The aim of this study was to project health-economic outcomes relevant to the German setting for the addition of pioglitazone to existing treatment regimens in patients with type 2 diabetes, evidence of macrovascular disease and at high risk of cardiovascular events. METHODS Event rates corresponding to macrovascular outcomes from the Prospective Pioglitazone Clinical Trial in Macr...

Journal: :Annals of internal medicine 2000
D A Ganz K M Kuntz G A Jacobson J Avorn

BACKGROUND 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (statin) therapy has proven efficacy in reducing the rate of coronary and cerebrovascular events in patients 75 years of age or younger with a history of myocardial infarction. However, in patients older than 75 years of age, the efficacy and potential cost-effectiveness of statins are unknown. OBJECTIVE To estimate the incr...

Journal: :Acta neurologica Taiwanica 2011
Din-E Shan Hui-Chen Wu Lu-Yin Chan Kang-Du Liu

Many expensive treatments have been developed for Parkinson's disease (PD), and a good cost-utility analysis is required. Quality-adjusted life-years (QALY) allows comparison of the cost-utility of different medical conditions. If a treatment strategy gives a patient an extra but unhealthy year, the QALY he obtained will be less than one. When a therapeutic strategy is more effective, but cause...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید